20615-94-5

Basic information

• Product Name: potassium 5-methyl-1,2,4-oxadiazole-3-carboxylate
• Synonyms: potassium 5-methyl-1,2,4-oxadiazole-3-carboxylate
• CAS NO: 20615-94-5
• Molecular Formula: C4H3KN2O3
• Molecular Weight: 166.17652
• Mol File: 20615-94-5.mol
• Article Data: 4

Chemical Properties

• Appearance: /
• Storage Temp.: under inert gas (nitrogen or Argon) at 2-8°C
• CAS DataBase Reference: potassium 5-methyl-1,2,4-oxadiazole-3-carboxylate(CAS DataBase Reference)
• NIST Chemistry Reference: potassium 5-methyl-1,2,4-oxadiazole-3-carboxylate(20615-94-5)
• EPA Substance Registry System: potassium 5-methyl-1,2,4-oxadiazole-3-carboxylate(20615-94-5)

Safety Data

• Hazardous Substances Data: 20615-94-5(Hazardous Substances Data)

Usage

General Description

Potassium 5-methyl-1,2,4-oxadiazole-3-carboxylate is a chemical compound that contains potassium and a 1,2,4-oxadiazole ring. It is commonly used as a pesticide and insecticide in agriculture due to its ability to effectively control pests and insects. potassium 5-methyl-1,2,4-oxadiazole-3-carboxylate is also used in the pharmaceutical industry for the synthesis of various pharmaceuticals and drugs. It has low toxicity towards mammals and is considered to be relatively safe for use in agricultural and pharmaceutical applications. However, it is important to handle this chemical with care and follow proper safety protocols when handling and using it.

Upstream product

• 40699-38-5 5-methyl-[1,2,4]oxadiazole-3-carboxylic acid ethyl ester 
• 19703-94-7 methyl 5-methyl-1,2,4-oxadiazole-3-carboxylate 

Downstream Products

• 155062-48-9 5-methyl-1,2,4-oxadiazole-3-carbonyl chloride 

Relevant articles and documents

POLYMYXIN ANALOGS USEFUL AS ANTIBIOTIC POTENTIATORS

The disclosure provides compounds of the formula (I) or a tautomer thereof, or a pharmaceutically acceptable salt of either of the foregoing. The variables A, R1, and R2 are defined in the disclosure. The disclosure further includes pharmaceutical compositions comprising a compound of formula I together with at least one pharmaceutically acceptable carrier. The disclosure also includes a method of sensitizing bacteria to an antibacterial agent, comprising administering to a patient infected with the bacteria, simultaneously or sequentially, a therapeutically effective amount of the antibacterial agent and a compound of formula (I).

Novel bi-cyclic or tri-cyclic heterocyclic compound

The present invention provides novel bi-cyclic or tri-cyclic compound represented by formula (I) or pharmaceutical acceptable salt thereof, [wherein, ring A is an aromatic group which may be substituted, one of X1 and X2 is a carbon atom, and another is a nitrogen atom, X3 is a nitrogen atom or CR2, X4 is a nitrogen atom or CR3, X5 is a sulfur atom or -CH=CH-, Z1 is an oxygen atom, -C(R6)(R7)-, -NH-, -C(R6)(R7)-NH-, -NH-C(R6)(R7)-, -C(R6)(R7)-O-, -O-C(R6)(R7)- or a single bone, one of Z2 and Z3 is CH and another one is a nitrogen atom, or both are nitrogen atoms, the other symbols are same as those defined in the specification.]